Sign up to save your podcasts
Or
Share #61 Tunable Radio Pharmaceuticals? The Founders of Ratio Therapeutics.
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
#61 Tunable Radio Pharmaceuticals? The Founders of Ratio Therapeutics.
Throughout many of the discussions on BioTech IQ it is clear that a combination of therapies is likely the answer to treating cancers and other diseases. This is a point well made by the guests on this episode of the show. CEO Jack Hoppin, PhD and Chief Scientific Officer, John Babich PhD are Co-Founders of Ratio Therapeutics. Both bring a successful background in biotech and not only discuss what their organization is doing but lessons they have learned as entrepreneurs in treatment development.
Don't miss it!
Support the show here: https://www.buymeacoffee.com/biotechiq
https://thebiotechiqpodcast.com
Don't forget to check out the YouTube Channel! https://www.youtube.com/@biotechiqpodcast4943
Check me out on LinkedIn https://www.linkedin.com/in/ammonr/
View all episodes
By Ammon RiveraThroughout many of the discussions on BioTech IQ it is clear that a combination of therapies is likely the answer to treating cancers and other diseases. This is a point well made by the guests on this episode of the show. CEO Jack Hoppin, PhD and Chief Scientific Officer, John Babich PhD are Co-Founders of Ratio Therapeutics. Both bring a successful background in biotech and not only discuss what their organization is doing but lessons they have learned as entrepreneurs in treatment development.
Don't miss it!
Support the show here: https://www.buymeacoffee.com/biotechiq
https://thebiotechiqpodcast.com
Don't forget to check out the YouTube Channel! https://www.youtube.com/@biotechiqpodcast4943
Check me out on LinkedIn https://www.linkedin.com/in/ammonr/